Where does Humacyte, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Humacyte, Inc. ranks #22,733 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Humacyte, Inc. hold?

Humacyte, Inc. holds 12 US utility patents granted between 2017 and 2025, spanning 9 technology areas.

What is Humacyte, Inc.'s Innovation Score?

Humacyte, Inc. has an Innovation Score of 30.8 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Humacyte, Inc.'s patent grant rate increasing or decreasing?

Humacyte, Inc.'s recent grant velocity is +20% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Humacyte, Inc.'s patents?

Humacyte, Inc.'s patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Humacyte, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Humacyte, Inc.

Q: What technology areas does Humacyte, Inc. focus on?

Humacyte, Inc.'s top technology area is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles) with 9 patents, ranking #332 of 2,589 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Humacyte ranks #22,733 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#22,733
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (30.8/100): 15.2
avg claims per patent: +20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22733 · US Corporation #22,733 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,733/49,997
PHOTO-FINISH Hopin
CPC-NARROW A61L · 9 areas
INNOV-THIN 30.8/100
CLAIMS-RICH 15.2 claims/avg
TYPE-USCORP US Corporation
VEL-UP +20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hopin Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Humacyte’s 30.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (29%) Velocity 2.2 pts (7%) Breadth 10.6 pts (34%) Claim depth 9.1 pts (30%)

Qualcomm Incorporated · highest

85
Adienne Pharma… · near

31
Vanderbilt Chemicals · near

31
Humacyte · this assignee

31
PanoScape Holdings · near

31
Jasper · near

31
3D Lighting… · lowest

7

What this shows Humacyte's Innovation Score is 30.8/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Humacyte?

Each dot is one of Humacyte’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Humacyte’s own 15.2 claims/patent is at or below the 15.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Humacyte vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Humacyte's grants concentrate

Humacyte, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 75% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2020. By volume, Humacyte sits between Hopin Ltd and HydraForce, Inc..

Humacyte's three-year grant acceleration

Humacyte, Inc. shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hopin

12
Hough Ear Institu…

12
Hughey & Phillips

12
Hulkman Innovatio…

12
Humaneyes

12
Hvidovre Hospital

12
Hydra Heating Ind…

12
Hydraforce

12
Humacyte ◀

12

What this shows Humacyte holds 12 patents at rank #22,733, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Humacyte

By rank, the assignees closest to #22,733 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Humacyte's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Humacyte, neither rank-band nor same-CPC leaders (those blocks stay above). In A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…), Humacyte ranks #332 of 2,589 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (31 here).

PanoScape Holdings, LLC 31 Jasper Technologies, Inc. 31 Adienne Pharma &biotech SA 31 Vanderbilt Chemicals, LLC 31

Humacyte's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Humacyte, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	25.0%
2019	2	16.7%
2020	1	8.3%
2021	3	25.0%
2024	2	16.7%
2025partial year	1	8.3%

Which technologies does Humacyte, Inc. patent most?

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 9

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 9

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 7

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 7

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

Y10T - Technical Subjects Covered BY Former US Classification 6

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

D04H - Making Textile Fabrics, e.g. From Fibres OR Filamentary Material ; Fabrics Made BY Such Processes OR Apparatus, e.g. Felts, Non-woven FABRICS; COTTON-WOOL; Wadding ; ; Non-woven Fabrics From Staple Fibres, Filaments OR Yarns, Bonded With AT Least ONE Web-like Material During Their Consolidation 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Humacyte, Inc.'s patent record in context - here's where to go next.

Humacyte, Inc.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 75% of its portfolio - see every assignee active in that class. Explore A61L
Ranked #22,733 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Humacyte, Inc. against Hopin Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.